SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Guardian Pharmacy Services, Inc. (GRDN) trades at a trailing P/E of 51.2, forward P/E of 30.9. Trailing earnings yield is 1.95%, forward earnings yield 3.24%. PEG 0.54 (Peter Lynch undervalued ≤1.0). Graham Number is $7.76.
Criteria proven by this page:
- VALUE (21/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 51.2).
- Forward P/E 30.9 (down from trailing 51.2) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.54 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 1.95% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 3.24% as earnings recover.
- Analyst consensus target $36.00 (-4.7% downside) — slight downside risk — the market may be ahead of analyst expectations.
Overall SharesGrow Score: 53/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
21/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GRDN
Valuation Multiples
P/E (TTM)51.2
Forward P/E30.9
PEG Ratio0.54
Forward PEG0.54
P/B Ratio12.26
P/S Ratio1.74
EV/EBITDA24.4
Per Share Data
EPS (TTM)$0.78
Forward EPS (Est.)$1.22
Book Value / Share$3.44
Revenue / Share$22.88
FCF / Share$1.27
Yields & Fair Value
Earnings Yield1.95%
Forward Earnings Yield3.24%
Dividend Yield0.00%
Graham Number$7.76
SharesGrow IV$60.97 (+61.3%)
Analyst Target$36.00 (-4.7%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2018 |
66.3 |
0.00 |
28.61 |
1.62 |
2.88% |
| 2019 |
44.8 |
0.90 |
0.00 |
1.39 |
3.53% |
| 2020 |
48.8 |
-5.86 |
25.30 |
1.32 |
1.11% |
| 2021 |
59.7 |
-3.28 |
40.69 |
1.23 |
1.78% |
| 2022 |
27.5 |
0.24 |
22.78 |
1.07 |
3.16% |
| 2023 |
40.7 |
-1.24 |
34.51 |
0.93 |
3.95% |
| 2024 |
-14.4 |
0.03 |
8.81 |
1.02 |
2.85% |
| 2025 |
38.1 |
-0.26 |
9.12 |
1.30 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2018 |
$0.24 |
$600.37M |
$14.68M |
2.4% |
| 2019 |
$0.36 |
$698.29M |
$21.75M |
3.1% |
| 2020 |
$0.33 |
$735.96M |
$19.94M |
2.7% |
| 2021 |
$0.27 |
$792.07M |
$16.31M |
2.1% |
| 2022 |
$0.58 |
$908.91M |
$35.42M |
3.9% |
| 2023 |
$0.39 |
$1.05B |
$23.9M |
2.3% |
| 2024 |
$-1.41 |
$1.23B |
$-87.29M |
-7.1% |
| 2025 |
$0.78 |
$1.45B |
$49.22M |
3.4% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$1.24 |
$1.21 – $1.25 |
$1.41B |
$1.4B – $1.43B |
3 |
| 2027 |
$1.36 |
$1.31 – $1.40 |
$1.53B |
$1.51B – $1.55B |
3 |
| 2028 |
$1.46 |
$1.44 – $1.48 |
$1.68B |
$1.66B – $1.7B |
2 |
